432 related articles for article (PubMed ID: 15993875)
1. Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease.
Umapathysivam K; Hopwood JJ; Meikle PJ
Clin Chim Acta; 2005 Nov; 361(1-2):191-8. PubMed ID: 15993875
[TBL] [Abstract][Full Text] [Related]
2. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F
Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133
[TBL] [Abstract][Full Text] [Related]
3. Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle.
Pauly DF; Johns DC; Matelis LA; Lawrence JH; Byrne BJ; Kessler PD
Gene Ther; 1998 Apr; 5(4):473-80. PubMed ID: 9614571
[TBL] [Abstract][Full Text] [Related]
4. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
[TBL] [Abstract][Full Text] [Related]
5. [A retrospective study of six patients with late-onset Pompe disease].
Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
[TBL] [Abstract][Full Text] [Related]
6. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
Raben N; Fukuda T; Gilbert AL; de Jong D; Thurberg BL; Mattaliano RJ; Meikle P; Hopwood JJ; Nagashima K; Nagaraju K; Plotz PH
Mol Ther; 2005 Jan; 11(1):48-56. PubMed ID: 15585405
[TBL] [Abstract][Full Text] [Related]
7. Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots.
Kallwass H; Carr C; Gerrein J; Titlow M; Pomponio R; Bali D; Dai J; Kishnani P; Skrinar A; Corzo D; Keutzer J
Mol Genet Metab; 2007 Apr; 90(4):449-52. PubMed ID: 17270480
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the molecular defect in infantile and adult acid alpha-glucosidase deficiency fibroblasts.
Beratis NG; LaBadie GU; Hirschhorn K
J Clin Invest; 1978 Dec; 62(6):1264-74. PubMed ID: 34626
[TBL] [Abstract][Full Text] [Related]
9. Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts.
Reuser AJ; Kroos M; Willemsen R; Swallow D; Tager JM; Galjaard H
J Clin Invest; 1987 Jun; 79(6):1689-99. PubMed ID: 3108320
[TBL] [Abstract][Full Text] [Related]
10. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
[TBL] [Abstract][Full Text] [Related]
11. Stabilising normal and mis-sense variant alpha-glucosidase.
Kakavanos R; Hopwood JJ; Lang D; Meikle PJ; Brooks DA
FEBS Lett; 2006 Aug; 580(18):4365-70. PubMed ID: 16846599
[TBL] [Abstract][Full Text] [Related]
12. Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper.
Chamoles NA; Niizawa G; Blanco M; Gaggioli D; Casentini C
Clin Chim Acta; 2004 Sep; 347(1-2):97-102. PubMed ID: 15313146
[TBL] [Abstract][Full Text] [Related]
13. Glycogen Storage Disease type II: genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry.
Hermans MM; Kroos MA; Smeitink JA; van der Ploeg AT; Kleijer WJ; Reuser AJ
Hum Mutat; 1998; 11(3):209-15. PubMed ID: 9521422
[TBL] [Abstract][Full Text] [Related]
14. Glycogenosis type II: identification and expression of three novel mutations in the acid alpha-glucosidase gene causing the infantile form of the disease.
Montalvo AL; Cariati R; Deganuto M; Guerci V; Garcia R; Ciana G; Bembi B; Pittis MG
Mol Genet Metab; 2004 Mar; 81(3):203-8. PubMed ID: 14972326
[TBL] [Abstract][Full Text] [Related]
15. Glycogen storage in multiple muscles of old GSD-II mice can be rapidly cleared after a single intravenous injection with a modified adenoviral vector expressing hGAA.
Xu F; Ding E; Migone F; Serra D; Schneider A; Chen YT; Amalfitano A
J Gene Med; 2005 Feb; 7(2):171-8. PubMed ID: 15515143
[TBL] [Abstract][Full Text] [Related]
16. [Characterization of alpha-glucosidase in skin fibroblasts in the diagnosis of glycogenosis type 2 (Pompe disease)].
Braulke T; Sandig KR
Kinderarztl Prax; 1984 Aug; 52(8):377-82. PubMed ID: 6384623
[No Abstract] [Full Text] [Related]
17. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory.
Goldstein JL; Young SP; Changela M; Dickerson GH; Zhang H; Dai J; Peterson D; Millington DS; Kishnani PS; Bali DS
Muscle Nerve; 2009 Jul; 40(1):32-6. PubMed ID: 19533645
[TBL] [Abstract][Full Text] [Related]
18. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.
van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA
Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258
[TBL] [Abstract][Full Text] [Related]
19. Late form of Pompe disease with glycogen storage in peripheral nerves axons.
Fidziańska A; Ługowska A; Tylki-Szymańska A
J Neurol Sci; 2011 Feb; 301(1-2):59-62. PubMed ID: 21109266
[TBL] [Abstract][Full Text] [Related]
20. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management.
Kishnani PS; Beckemeyer AA; Mendelsohn NJ
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):1-7. PubMed ID: 22253049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
